Browsing Tag
CN201
1 post
Merck to acquire Curon Biopharmaceutical’s CN201 in strategic oncology expansion
Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, has secured a…
Business news, market intelligence, and global industry analysis.